Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 20, 2000

View Archived Issues

Infertility induced by immunization against zona pellucida protein in vivo

Licensing opportunity from NIH: smad3 protein inhibition to enhance wound healing

Licensing opportunity from NIH: chimeric viruses as vaccine candidates

FDA approves IND for Indena/Bayer anticancer compound

Cell Therapeutics seeks European approval of Trisenox

E.C. approves Roche's CellCept for prevention of liver transplant rejection

Allergan returns rBPI ophthalmic rights to Xoma

Immune Network begins DAD2000 Alzheimer's disease trial

Bexxar BLA filing accepted by FDA

Ceramide analogue with promising pharmacological profile presented at recent cancer symposium

RPR-116258A: results from phase I program discussed at NCI-EORTC-AACR

Y-27632 explored as vasodilator for HF

Panacea begins preclinical studies with PAN-346 for brain cancers

Highly lipophilic silatecans highlighted at AAPS and NCI-EORTC-AACR meetings

Procyon BioPharma and Biovation finalize monoclonal antibody collaboration

U.K. research leads to orally active, nonestrogenic steroid sulfatase inhibitors for breast cancer

ET-1 antisense ODNs show antiarrhythmic effects in AMI

Further clinical data on BMS-232632, presented at AIDS congress, support use in combination therapy

MCI-154 shown to increase myofilament cooperativity

Profile of tipranavir indicates suitability for inclusion in combination antiretroviral regimens

Xanthine-based inhibitors of IL-12 signaling patented by Cell Therapeutics

Triarylimidazoles synthesized at SmithKline Beecham active as inhibitors of TGF-beta signaling

AstraZeneca presents new P2X7 receptor antagonists and their potential use

Novel thrombin inhibitor prodrugs for oral administration

Potential new treatments for urinary incontinence described by Sanofi-Synthelabo

New erythromycin derivatives exert potent antimycobacterial activity

Recently issued patent covers Meiji Seika's new lipid-lowering agents

New ultrasound contrast agent PB-127 in development for myocardial imaging

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 10, 2025.
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
US lawmakers demand that Kennedy be held accountable
BioWorld
As the systematic dismantling of the U.S. vaccine schedule escalates, the demands to hold Health and Human Services Secretary Robert Kennedy accountable are...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...